Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

News2001March › Marrow transplants don't help patients with lymphoma › March 2001

Marrow transplants don't help patients with lymphoma

Patients with aggressive non Hodgkin's lymphoma don't necessarily benefit from bone marrow transplant (BMT), a new study shows

Patients with aggressive non Hodgkin's lymphoma don't necessarily benefit from bone marrow transplant (BMT), a new study shows.

Instead, they appear to do just as well when given standard chemotherapy as when given a high dose regime and BMT.

The finding is based on a study of 200 patients who were randomised to either standard chemotherapy or a more aggressive high dose regime followed by BMT. At follow up at 53 months, 61 per cent of the patients who received BMT were free from disease progression and 68 per cent were still alive. However, in the standard treatment group, 56 per cent were free from disease progression and 77 per cent were still alive.

Aggressive approaches to NHL, argue the researchers, should not be the first line in treatment, but reserved for those patients whose disease has failed to respond to less aggressive approaches (J Nat Cancer Inst, 2001; 93: 4-5, 22-30).

BMT is increasingly used to treat a wide variety of cancers. Apart from being of questionable value, it can also lead to acute kidney failure, as documented in a recent review.

Of those undergoing BMT, 5-15 per cent may develop acute kidney failure and, among long term survivors, 5-20 per cent will develop chronic kidney failure.

The reasons why BMT is associated with such poor outcomes have to do with the way a patient is prepared for the procedure. Usually this involves pre transplantation high dose chemotherapy and 'conditioning' with total body irradiation. Such procedures deplete the body of helpful leucocytes, leaving it open to serious infection. Often, renal failure is evident within the first 30 days after a transplant (Lancet, 2001; 357: 6-7).


You may also be interested in...

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved